255 related articles for article (PubMed ID: 26918339)
21. High prevalence of RET proto-oncogene activation (RET/PTC) in papillary thyroid carcinomas.
Lam KY; Lo CY; Leung PS
Eur J Endocrinol; 2002 Dec; 147(6):741-5. PubMed ID: 12457448
[TBL] [Abstract][Full Text] [Related]
22. Molecular analysis of the RET and NTRK1 gene rearrangements in papillary thyroid carcinoma in the Polish population.
Brzeziańska E; Karbownik M; Migdalska-Sek M; Pastuszak-Lewandoska D; Włoch J; Lewiński A
Mutat Res; 2006 Jul; 599(1-2):26-35. PubMed ID: 16483615
[TBL] [Abstract][Full Text] [Related]
23. Prevalence of RET/PTC1 and RET/PTC3 gene rearrangements in Chennai population and its correlation with clinical parameters.
Rao PJ; Vardhini NV; Parvathi MV; Murthy PB; Sudhakar G
Tumour Biol; 2014 Oct; 35(10):9539-48. PubMed ID: 24957039
[TBL] [Abstract][Full Text] [Related]
24. [Frequency of RET/PTC rearrangement and somatic BRAF mutation in papillary thyroid cancer].
Rumiantsev PO; Zaletaev DV; Vasil'ev EV; Saenko VA; Il'in AA; Rumiantseva UV; Abrosimov AIu; Medvedev VS
Vopr Onkol; 2006; 52(2):145-9. PubMed ID: 17195637
[TBL] [Abstract][Full Text] [Related]
25. BRAFV600E and RET/PTC Promote Proliferation and Migration of Papillary Thyroid Carcinoma Cells In Vitro by Regulating Nuclear Factor-κB.
Zhou D; Li Z; Bai X
Med Sci Monit; 2017 Nov; 23():5321-5329. PubMed ID: 29117154
[TBL] [Abstract][Full Text] [Related]
26. [Pooled Analysis of RET/PTC Gene Rearrangement Rate in Sporadic and Radiogenic Thyroid Papillary Carcinoma].
Ushenkova LN; Koterov AN; Biryukov AP
Radiats Biol Radioecol; 2015; 55(4):355-88. PubMed ID: 26601537
[TBL] [Abstract][Full Text] [Related]
27. DNA fragile site breakage as a measure of chemical exposure and predictor of individual susceptibility to form oncogenic rearrangements.
Lehman CE; Dillon LW; Nikiforov YE; Wang YH
Carcinogenesis; 2017 Mar; 38(3):293-301. PubMed ID: 28069693
[TBL] [Abstract][Full Text] [Related]
28. Preferential induction of RET/PTC1 rearrangement by X-ray irradiation.
Mizuno T; Iwamoto KS; Kyoizumi S; Nagamura H; Shinohara T; Koyama K; Seyama T; Hamatani K
Oncogene; 2000 Jan; 19(3):438-43. PubMed ID: 10656692
[TBL] [Abstract][Full Text] [Related]
29. Effects of siRNA on RET/PTC3 junction oncogene in papillary thyroid carcinoma: from molecular and cellular studies to preclinical investigations.
Ali HM; Urbinati G; Chapuis H; Desmaele D; Bertrand JR; Couvreur P; Massaad-Massade L
PLoS One; 2014; 9(4):e95964. PubMed ID: 24759995
[TBL] [Abstract][Full Text] [Related]
30. RET/PTC rearrangements arising from a small population of papillary thyroid carcinoma cells, possible candidate for passenger mutation.
Nakazawa T; Murata S; Kondo T; Niu D; Mochizuki K; Kawasaki T; Yamane T; Nakamura N; Katoh R
Virchows Arch; 2009 Jul; 455(1):35-41. PubMed ID: 19495791
[TBL] [Abstract][Full Text] [Related]
31. [BRAFV599E mutation and RET/PTC rearrangements in papillary thyroid carcinoma].
Zhu XL; Zhou XY; Zhu XZ
Zhonghua Bing Li Xue Za Zhi; 2005 May; 34(5):270-4. PubMed ID: 16181547
[TBL] [Abstract][Full Text] [Related]
32. Transcript level modulates the inherent oncogenicity of RET/PTC oncoproteins.
Richardson DS; Gujral TS; Peng S; Asa SL; Mulligan LM
Cancer Res; 2009 Jun; 69(11):4861-9. PubMed ID: 19487296
[TBL] [Abstract][Full Text] [Related]
33. The prevalence of RET/PTC mutations in papillary thyroid cancers in Turkish population and its relation between tumor histopathology and prognostic factors.
Erdoğan M; Berdeli A; Karadeniz M; Ertan Y; Cetinkalp S; Saygili F; Tuncyurek M; Yilmaz C; Tuzun M; Kabalak T; Uluer H; Ozgen AG
Exp Clin Endocrinol Diabetes; 2008 Apr; 116(4):225-30. PubMed ID: 18393128
[TBL] [Abstract][Full Text] [Related]
34. [Oncogenes RET/PTC and mechanisms of their involvement in thyroid cancerogenesis].
Voskoboĭnyk LH
Ukr Biokhim Zh (1999); 2009; 81(6):17-25. PubMed ID: 20387655
[TBL] [Abstract][Full Text] [Related]
35. Fine-needle aspiration molecular analysis for the diagnosis of papillary thyroid carcinoma through BRAF V600E mutation and RET/PTC rearrangement.
Pizzolanti G; Russo L; Richiusa P; Bronte V; Nuara RB; Rodolico V; Amato MC; Smeraldi L; Sisto PS; Nucera M; Bommarito A; Citarrella R; Lo Coco R; Cabibi D; Lo Coco A; Frasca F; Gulotta G; Latteri MA; Modica G; Galluzzo A; Giordano C
Thyroid; 2007 Nov; 17(11):1109-15. PubMed ID: 17727338
[TBL] [Abstract][Full Text] [Related]
36. [The correlation between BRAF mutations, RET/PTC rearrangements and platelet-derived growth factor B expression in papillary thyroid carcinomas].
Wang P; Wang YG; Zhao WJ; Fu YD; Wang L; Wang F; Zhao SH
Zhonghua Nei Ke Za Zhi; 2012 Dec; 51(12):987-91. PubMed ID: 23327964
[TBL] [Abstract][Full Text] [Related]
37. RET/PTC rearrangements preferentially occurred in papillary thyroid cancer among atomic bomb survivors exposed to high radiation dose.
Hamatani K; Eguchi H; Ito R; Mukai M; Takahashi K; Taga M; Imai K; Cologne J; Soda M; Arihiro K; Fujihara M; Abe K; Hayashi T; Nakashima M; Sekine I; Yasui W; Hayashi Y; Nakachi K
Cancer Res; 2008 Sep; 68(17):7176-82. PubMed ID: 18757433
[TBL] [Abstract][Full Text] [Related]
38. A novel RET/PTC variant detected in a pediatric patient with papillary thyroid cancer without ionization history.
Halkova T; Dvorakova S; Vaclavikova E; Sykorova V; Vcelak J; Sykorova P; Vlcek P; Reboun M; Katra R; Kodetova D; Schrumpf M; van Wezel T; Morreau H; Bendlova B
Hum Pathol; 2015 Dec; 46(12):1962-9. PubMed ID: 26472164
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of RET/PTC rearrangements in thyroid papillary carcinomas: effects of the detection methods and genetic heterogeneity.
Zhu Z; Ciampi R; Nikiforova MN; Gandhi M; Nikiforov YE
J Clin Endocrinol Metab; 2006 Sep; 91(9):3603-10. PubMed ID: 16772343
[TBL] [Abstract][Full Text] [Related]
40. RET/papillary thyroid cancer rearrangement in nonneoplastic thyrocytes: follicular cells of Hashimoto's thyroiditis share low-level recombination events with a subset of papillary carcinoma.
Rhoden KJ; Unger K; Salvatore G; Yilmaz Y; Vovk V; Chiappetta G; Qumsiyeh MB; Rothstein JL; Fusco A; Santoro M; Zitzelsberger H; Tallini G
J Clin Endocrinol Metab; 2006 Jun; 91(6):2414-23. PubMed ID: 16595592
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]